medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Number 3

<< Back Next >>

Ann Hepatol 2017; 16 (3)

Prospective Indian Study of DILI with Confirmed Causality Using the Roussel Uclaf Causality Assessment Method (RUCAM): A Report of Excellence

Teschke R, Danan G

Language: English
References: 15
Page: 324-325
PDF size: 105.92 Kb.


Text Extraction

One of the highlights of this issue of Annals of Hepatology is the analysis of DILI cases from India by Rathi, et al., since all cases were prospectively evaluated with RUCAM, the widely used tool for causality assessment worldwide. This approach provided valuable well-established results on various aspects of DILI.
The study of Rathi, et al. from the Department of Gastroenterology of the Lokmanya Tilak Municipal Medical College and General Hospital in Sion, Mumbai, Maharashtra in India is an outstanding report on drug induced liver injury (DILI) and will serve as a paradigm how future cases of DILI should be analyzed and prepared for publication. Their careful analysis of a 2-year single center prospective cohort study illustrates the challenging aspects of DILI and especially causality assessment.


REFERENCES

  1. Rathi C, Pipaliya N, Patel R, Ingle M, Phadke A, Sawant P. Drug induced liver injury at a tertiary hospital in India: Etiology, clinical features and predictors of mortality. Ann Hepatol 2017; 16: 442-50.

  2. Danan G, Bénichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-30.

  3. Bénichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs - II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46: 1331-6.

  4. Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci; Special issue: Drug, herb, and dietary supplement hepatotoxicity 2016; 17: 14. DOI: 10.3390/ijms17010014.

  5. Björnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing. J Hepatol 2012; 56: 374-80.

  6. Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, García-Muñoz B, et al, Spanish Group for the Study of Drug-induced Liver Disease. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129: 512-21.

  7. Zhu Y, Niu M, Chen J, Zou ZS, Ma ZJ, Liu SH, Wang RL, et al. Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. J Gastroenterol Hepatol 2016; 31: 1476-82. DOI: 10.1111/jgh.13323.

  8. Teschke R, Frenzel C, Wolff A, Eickhoff A, Schulze J. Drug induced liver injury: accuracy of diagnosis in published reports. Ann Hepatol 2014; 13: 248-55.

  9. Björnsson ES. Hepatotoxicity by drugs: the most common implicated agents. Int J Mol Sci 2016; 17: 224. DOI: 10.3390/ ijms17020224.

  10. Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C. Herbal hepatotoxicity: suspected cases assessed for alternative causes. Eur J Gastroenterol Hepatol 2013; 25: 1093-8. DOI: 10.1097/MCG.0b013e3283603e89.

  11. Zambrone FAD, Corrêa CL, Sampaio do Amaral LM. A critical analysis of the hepatotoxicity cases described in the literature related to Herbalife products. Braz J Pharm Sci 2015; 51. Available at: http://dx.oi.org/10.1590/S1984-82502015 000400004

  12. Teschke R, Schwarzenboeck A, Frenzel C, Schulze J, Eickhoff A, Wolff A. The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem. Ann Hepatol 2016; 15: 91-119. Available at: http://www.annalsofhepatology.com.mx/revista/numeros/ 2016/HP161-12-Mystery%20(web)%20(FF_041215V) _PROTEGIDO%20(1).pdf

  13. Teschke R, Eickhoff A. The Honolulu Liver disease cluster at the Medical Center: Its mysteries and challenges. Int J Mol Sci 2016, 17(4): 476. DOI: 10.3390/ijms17040476.

  14. Teschke R, Eickhoff A. Suspected liver injury and the dilemma of causality. Dig Dis Sci 2017; 62: 1095-8. DOI: 10.1007/ s10620-016-4442-5.

  15. Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines 2016; 3(18). DOI: 10.3390/medicines3030018




2020     |     www.medigraphic.com